A Study of PER-001 in Participants With Open-Angle Glaucoma

NCT05822245 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Open-angle Glaucoma

Interventions

DRUG: PER-001 Intravitreal Implant - Low Dose
DRUG: PER-001 Intravitreal Implant - High Dose
DRUG: PER-001 Intravitreal Implant - Sham

Sponsor

Perfuse Therapeutics, Inc.